Review| Volume 60, ISSUE 1, P32-40, January 2007

Incidence, mortality and survival in cutaneous melanoma


      Cutaneous melanoma remains a challenge despite increased levels of awareness, education and targeted health policies. Worldwide incidence rates for cutaneous melanoma have risen faster than those for any other malignancy in Caucasian populations over the last 30 years.
      Despite improving survival rates (defined as the ratio of those who survive the disease against incidence) over this period, mortality rates, generally, have continued to climb. Mortality from melanoma is greater than that caused by all other types of skin cancer, especially in men. In Britain the percentage of increase in the male age standardised mortality rate surpassed that of all other malignancies assessed (1993–2002) by Cancer Research UK.
      A literature-based study was conducted with review of publications identified through Medline and EMBase, 1980–December 2005, databases.
      We present a review of the current literature on incidence, mortality and survival rates of melanoma including a discussion on the aetiological factors, behaviour modification associated with public education campaigns and recent health policies and the effect these are having on melanoma figures.
      It is likely that any fall in mortality rates from melanoma in the near future will be secondary to early detection. Changes resulting from primary prevention are unlikely to be noticeable for several decades.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Statistical Information Team Cancer Research UK. Information Resource Centre. Available from: <>; 2005.

        • Katsambas A.
        • Nicolaidou E.
        Cutaneous malignant melanoma and sun exposure.
        Arch Dermatol. 1996; 132: 444-459
        • Gilchrest B.A.
        • Eller M.S.
        • Geller A.C.
        • et al.
        The pathogenesis of melanoma induced by ultraviolet radiation.
        N Engl J Med. 1999; 340: 1341-1348
        • Armstong B.K.
        • Kricker A.
        How much melanoma is caused by sun?.
        Melanoma Res. 1993; 3: 395-401
        • Garland C.F.
        • Garland F.C.
        • Gorham E.D.
        Epidemiologic evidence for the different roles of ultraviolet A and B radiation in melanoma mortality rates.
        Ann Epidemiol. 2003; 13: 395-404
        • Tucker M.A.
        • Goldstein A.M.
        Melanoma etiology: where are we?.
        Oncogene. 2003; 22: 3042-3052
        • Marks R.
        • Whiteman D.
        Sunburn and melanoma: how strong is the evidence?.
        BMJ. 1994; 308: 75
        • Zanetti R.
        • Francesschi S.
        • Rosso S.
        • et al.
        Cutaneous melanoma and sunburns in childhood in a southern European population.
        Eur J Cancer. 1992; 28: 1172-1176
        • Khalat M.
        • Vail A.
        • Parkin M.
        • et al.
        Mortality from melanoma in migrants to Australia: variation by age at arrival and duration of stay.
        Am J Epidemiol. 1992; 135: 1103-1113
        • Holman C.A.
        • Armstrong B.K.
        • Heenan P.J.
        • et al.
        The causes of malignant melanoma: results from the West Australian Lions Melanoma Research Project. Recent results.
        Cancer Res. 1986; 102: 18-37
        • Elwood J.M.
        • Gallagher R.P.
        • Hill G.B.
        • et al.
        Cutaneous melanoma in relation to intermittent and constant sun exposure – the Western Canada Melanoma Study.
        Int J Cancer. 1985; 35: 427-433
        • Gallagher R.P.
        • Spinelli J.J.
        • Lee T.K.
        Tanning beds, sunlamps and risk of cutaneous malignant melanoma.
        Cancer Epidemiol Biomarkers Prev. 2005; 14: 562-566
        • Pion I.A.
        • Rigel D.S.
        • Garfinkel L.
        • et al.
        Occupation and the risk of malignant melanoma.
        Cancer. 1995; 75: 637-644
      2. English D. The Cancer Council Victoria, Australia. Primary prevention of melanoma in Australia. In: Presented at the sixth World Congress on Melanoma. Vancouver, BC; September 2005 [Abstract 074].

        • Hall C.
        Holiday at home or abroad?.
        Financial mail. July 25, 2005 (Available from:)
        • Swerdlow A.J.
        • dos Santos Silva I.
        • Doll R.
        Cancer incidence and mortality in England and Wales: trends and risk factors.
        Oxford University Press, Oxford2001
        • Miles A.
        • Waller J.
        • Hiom S.
        • et al.
        Skin cancer knowledge and preventive behaviour in a British population representative sample.
        Health Educ Res. 2005; 20: 579-585
        • Davis N.
        Modern concepts of melanoma and its management.
        Ann Plast Surg. 1978; 1: 628-629
        • Coory M.
        • Baade P.
        • Aitkin J.
        • et al.
        Trends for in-situ and invasive melanoma in Queensland, Australia, 1982–2002.
        Cancer Causes Control. 2006; 17: 21-27
        • The World Health Organization
        The World Health Organization recommends that no person under 18 should use a sunbed.
        WHO Media Centre, March 17, 2005 (Available from:)
        • Quinn M.
        • Babb P.
        • Brock A.
        • et al.
        Cancer trends in England and Wales 1950–1999.
        (Vol. SMPS no. 66) TSO, 2001
        • Office for National Statistics
        Cancer Statistics registrations: registrations of cancer diagnosed in 2002, England.
        (Series MB1 no.33) National Statistics, London2005 (Available from:)
      3. Ries L.A.G. Eisner M.P. Kosary C.L. Hankey B.F. Miller B.A. Clegg L. Mariotto A. Feuer E.J. Edwards B.K. SEER Cancer Statistics Review, 1975–2002. National Cancer Institute, Bethesda, MDNovember 2004 ([based on November 2004 SEER data submission, posted to the SEER web site 2005])
        • Ferrone C.R.
        • Ben Porat L.
        • Panageas K.S.
        • et al.
        Clinicopathological features of and risk factors for multiple primary melanomas.
        JAMA. 2005; 294: 1647-1654
        • Australian Institute of Health and Welfare
        • de Looper M.
        • Bhatia K.
        Australian Health Trends 2001.
        (AIHW Cat. no. PHE 24) AIHW, Canberra2001 (Available from:)
        • de Vries E.
        • Tyczynski J.
        • Parkin D.
        Cutaneous malignant melanoma in Europe.
        ENCR. 2003; 4: 1-4
      4. MacKie R. Melanoma incidence in the west of Scotland over the 25 years. In: Presented at the sixth World Congress on Melanoma. Vancouver, BC; September 2005 [Abstract 039].

        • MacKie R.
        • Bray C.
        • Hole D.
        • et al.
        Incidence and survival from malignant melanoma in Scotland: an epidemiological study.
        Lancet. 2002 Aug 24; 360: 587-591
      5. MacKie R, Bray C, Hole D, et al. The changing incidence of cutaneous melanoma in the west of Scotland and Queensland 1982–2001, an intercontinental comparison. In: Presented at the sixth World Congress on Melanoma. Vancouver, BC; September 2005 [Abstract BE3-1].

        • Balch C.M.
        • Soong S.J.
        • Milton G.W.
        • et al.
        Changing trends in cutaneous melanoma over a quarter of a century in Alabama, USA and New South Wales, Australia.
        Cancer. 1983; 52: 1748-1753
        • Bulliard J.-L.
        • Cox B.
        Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969–1993.
        Int J Epidemiol. 2000; 29: 416-423
        • Kwan T.Y.
        • Belke T.W.
        • Enta T.
        Sex differences in the anatomical distribution of melanocytic naevi in Canadian Hutterite children.
        J Cutan Med Surg. 2000; 4: 58-62
        • Giles G.G.
        • Armstrong B.K.
        • Burton R.C.
        • et al.
        Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994.
        BMJ. 1996; 312: 1121-1125
        • Baade P.
        • Coory M.
        Trends in melanoma mortality in Australia: 1950–2002 and their implications for melanoma control.
        Aust NZ J Public Health. 2005; 29: 383-386
        • Hall H.I.
        • Miller D.R.
        • Annas G.D.
        • et al.
        Update on the incidence and mortality from melanoma in the United States.
        J Am Acad Dermatol. 1999; 40: 35-42
      6. Office for National Statistics. Mortality statistics: cause. England and Wales 2001. Series DH2 no. 28 Available from: National Statistics website at

        • Coleman M.P.
        • Babb P.O.
        • Damiecki P.
        • et al.
        Cancer survival trends in England and Wales. 1971–1995. Deprivation and NHS region.
        The Stationary Office, London1999
        • Coleman M.P.
        • Rachet B.
        • Woods L.M.
        Trends in socioeconomic inequalities in cancer survival in England and Wales up to 2001.
        Br J Cancer. 2004; 90: 1367-1373
        • Parkin D.M.
        • Bray F.
        • Ferlay J.
        • et al.
        Global cancer statistics, 2002.
        CA Cancer J Clin. 2005 Mar–Apr; 55: 74-108
        • McLeod G.R.
        • Davis N.
        • Sober A.J.
        History of melanoma.
        in: Balch C.M. Houghton A.N. Sober A.J. Soong S. Cutaneous melanoma. 4th ed. QMP, St Louis, Missouri2003: 9-10
      7. Weinstock MA. Sun protection and early detection: do we have the balance right? In: Presented at the sixth World Congress on Melanoma. Vancouver, BC; September 2005 [Abstract 114].

        • Lim H.W.
        • Gilchrest B.A.
        • Cooper K.D.
        • et al.
        Sunlight, tanning booths, and vitamin D.
        Am Acad Dermatol. 2005; 52: 868-876
      8. Halpern A. Primary prevention of skin cancer in the United States. In: Presented at the sixth World Congress on Melanoma. Vancouver, BC; September 2005 [Abstract 075].

        • Diffey B.L.
        A quantitative estimate of melanoma mortality from ultraviolet A sunbed use in the UK.
        Br J Dermatol. 2003; 149: 578-581
        • Dennis L.K.
        Analysis of the melanoma epidemic, both apparent and real. Data from the 1973 through 1994 surveillance, epidemiology and end results program registry.
        Arch Dermatol. 1999; 134: 275-280
        • Severi G.
        • Giles G.G.
        • Robertson C.
        • et al.
        Mortality from cutaneous melanoma: evidence for contrasting trends between populations.
        Br J Cancer. 2000; 82: 1887-1891
        • Chamberlain A.J.
        • Fritschi L.
        • Giles G.G.
        • et al.
        Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia.
        Arch Dermatol. 2002; 138: 609-614
        • Richardson B.
        • Price A.
        • Wagner M.
        • et al.
        Investigation of female survival benefit in metastatic melanoma.
        Br J Cancer. 1999; 80: 2025-2033
      9. Dennis L, Ritchie J, VanBeek M, et al. Tanning attitudes and beliefs among sorority and fraternity students. In: Presented at the sixth World Congress on Melanoma. Vancouver, BC; September 2005 [Abstract BE3-5].

        • Expert Group on climate change and health in the UK
        Health effects of climate change in the UK.
        Department of Health, London2001 (Available from:)
        • Austoker J.
        Cancer prevention in primary care: melanoma: prevention and early diagnosis.
        BMJ. 1994; 308: 1682-1686
        • American Cancer Society
        Overview: skin cancer – melanoma, how many people get melanoma skin cancer?.
        (Available from:)
        • US Preventive Services Taskforce
        Guide to clinical preventive services.
        2nd ed. Williams and Williams, Baltimore1996
      10. Diffey B. Should we be surprised that sunscreens appear not to be protective in melanoma? In: Presented at the sixth World Congress on Melanoma. Vancouver, BC; September 2005 [Abstract 121].

        • Garland C.
        • Garland F.
        • Gorham E.
        Rising trends in melanoma: an hypothesis concerning sunscreen effectiveness.
        Ann Epidemiol. 1993; 3: 103-110
        • Pacifico M.D.
        • Grover R.
        • Sanders R.
        Use of an early-detection strategy to improve disease control in melanoma patients.
        Br J Plast Surg. 2004 Mar; 57: 105-111
        • Carli P.
        • Nardini P.
        • Crocetti E.
        • et al.
        Frequency and characteristics of melanomas missed at a pigmented lesion clinic: a registry-based study.
        Melanoma Res. 2004 Oct; 14: 403-407
        • Helfand M.
        • Mahon S.M.
        • Eden K.B.
        • et al.
        Screening for skin cancer.
        Am J Prev Med. 2001; 20: 47-58
        • Rager E.L.
        • Bridgeford E.P.
        • Ollila D.W.
        Cutaneous melanoma: update on prevention, screening, diagnosis and treatment.
        Am Fam Physician. 2005; 72: 269-276
        • Ferlay J.
        • Bray F.
        • Pisani P.
        • et al.
        GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide.
        (IARC Cancer Base no. 5, version 2.0) IARC Press, Lyon, France2004
        • Sant M.
        • Aareleid T.
        • Berrino
        • et al.
        EUROCARE-3: survival of cancer patients diagnosed 1990–1994 – results and commentary.
        Ann Oncol. 2003; 14: v61-v118